Update on the Management of Parkinson’s Disease for General Neurologists

Author:

Pirtošek Zvezdan1ORCID,Bajenaru Ovidiu2,Kovács Norbert3ORCID,Milanov Ivan4,Relja Maja5,Skorvanek Matej6

Affiliation:

1. Department of Neurology, University Medical Center & Chair of Neurology, Medical Faculty University of Ljubljana, Ljubljana, Slovenia

2. Department of Clinical Neurosciences, University of Medicine and Pharmacy “Carol Davila”, Bucharest, Romania

3. Department of Neurology Medical School University of Pecs, Pecs, Hungary

4. Department of Neurology, Multiprofile University Hospital for Active Treatment in Neurology and Psychiatry “St. Naum”, Sofia, Bulgaria

5. Movement Disorders Center, Department of Neurology, School of Medicine, University Hospital Center Zagreb, Zagreb, Croatia

6. Department of Neurology. Medical Faculty, P. J. Safarik University and Department of Neurology University Hospital of L. Pasteur, Kosice, Slovakia

Abstract

Management of Parkinson’s disease (PD) is complicated due to its progressive nature, the individual patient heterogeneity, and the wide range of signs, symptoms, and daily activities that are increasingly affected over its course. The last 10–15 years have seen great progress in the identification, evaluation, and management of PD, particularly in the advanced stages. Highly specialized information can be found in the scientific literature, but updates do not always reach general neurologists in a practical and useful way, potentially creating gaps in knowledge of PD between them and neurologists subspecialized in movement disorders, resulting in several unmet patient needs. However, general neurologists remain instrumental in diagnosis and routine management of PD. This review provides updated practical information to identify problems and resolve common issues, particularly when the advanced stage is suspected. Some tips are provided for efficient communication with the members of a healthcare team specialized in movement disorders, in order to find support at any stage of the disease in a given patient, and especially for a well-timed decision on referral.

Funder

AbbVie

Publisher

Hindawi Limited

Subject

Psychiatry and Mental health,Neurology (clinical),Neuroscience (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3